| Abstrakt: |
The US Patent and Trademark Office has published a patent application for nucleic acid vaccines. The inventors propose a vaccine platform that uses nucleic acids to create self-assembling nanoparticles with vaccine antigens. This approach aims to improve the immune response and simplify manufacturing. The patent application suggests that this technology could be used to treat a range of diseases, including cancer, cardiovascular diseases, and infectious diseases. The document provides a detailed description of the composition and its potential applications. [Extracted from the article] |
